 Your new post is loading...
 Your new post is loading...
|
Scooped by
Lionel Reichardt / le Pharmageek
January 6, 2019 9:43 AM
|
We've consulted our crystal ball (okay, actually our team chat) and come up with some predictions for 2019, along with the key trends that stood out to our analysts in 2018. Ten trends that stood out in 2018: - Health applications of chatbots go from shiny and new to tried and true, and pioneering companies are beginning to figure out how to use them to triage inquiries and smooth the customer experience without falling afoul of legal regulatory boundaries.
- Health AI has a “Last Mile problem” – Watson shows great promise but foibles recall those of driverless cars. The technology is amazing at validating diagnoses against what an MSK oncologist would say, but continues to suffer from cultural and organization-specific blind spots and data constraints, and with lives at stake, close ain’t gonna cut it.
- GDPR and its California cousin prompt a rethink of data privacy protections, forcing industry to get its act together, build out data management capabilities and negotiate with patients for the use of their data.
- Substantial improvements in wearables, with ECG applications showing particular promise and BG meters getting smaller and more sophisticated -- but wellness programs’ worth is increasingly in doubt.
- Physicians’ rage at EHRs boils over in the U.S., even as their potential to tap big data begins to bear fruit; voice tech shows promise to alleviate some of that suffering, but it’s early days yet for the technology. At least the NHS is throwing out its fax machines?
- Payer and IDN marketing comes into focus for pharma amid continued erosion in physician prescribing autonomy.
- Pharmas bring on high-level digital and consumer marketing expertise, with several leading companies appointing Chief Digital Officers for the first time (Lidia Fonseca joining Pfizer from Quest Diagnostics, Karenann Terrell joining GSK from Walmart, and Bertrand Bodson joining Novartis from Sainsbury's Argos).
- An Amazon-induced scramble for scale sees the rise of a new type of vertically-integrated healthcare megalith in the U.S., from CVS+Aetna to Cigna+ExpressScripts, UnitedHealth+DaVita, Humana’s hospice push, etc.
- Social media’s mystery fades as a small set of dominant platforms selling out-of-box solutions (Facebook on the consumer side, LinkedIn, Doximity and Sermo for professionals) emerge.
- Copay accumulators emerge as the latest weapon in the eternal discounting arms race between pharma and insurers in the U.S. Could this be the end for co-pay cards and coupons? Probably not, but stay tuned!
Nine predictions for 2019: - The sun begins to set on the Age of the Pharmaceutical Sales Rep as automation shifts an increasing number of traditional rep responsibilities over to chatbots, on-demand webinars and other forms of non-personal engagement. This won’t happen overnight – physicians in many markets and specialties continue to value the rep relationship – but in 2019, we’ll begin to see field forces taper down earlier in the product cycle as companies ramp up investment in NPP (M3’s partnership with Novartis Oncology on a sample-ordering Amazon Ping button is a prime (rimshot) example of this). Given the enormous hegemonic power pharma sales orgs have exerted on larger commercial orgs, this will portend broader shifts in pharma commercial culture.
- Med affairs faces automation, too, as more pharmas tinker with using chatbots – tightly scripted, narrow pathway, clear guardrails – to triage physician and other HCP inquiries. You can already see this phenomenon on Pfizer’s medical affairs site, where Medibot, reminiscent of the Jetsons’ Uniblab, fields physicians’ questions.
- Pharma’s initial forays into chatbots and AI will be concentrated in apps for healthcare professionals, sidestepping the higher regulatory burden that comes with consumer applications. They’ll be tightly scripted, narrowly focused and clunkily utilitarian. But a few brave pharmas will branch out into consumer-directed efforts – as Novartis has already with its Alia Facebook Messenger chatbot.
- Facebook is 2019’s Outcome Health – pharma just can’t quit it, but the platform is losing its luster, and a chunk of its user base in The West, amid a cascade of damaging revelations about its sketchy handling of customer data and exploitation by malevolent state and extra-state actors around the globe. Add to that the parallel collapse in advertiser confidence and we may see pharmas hedging their bets by placing more of their budget in endemic health platforms.
- Massive real-time patient data and genetic data sets come into play for clinical trials and patient care. Apple Watch and its competitors are becoming standard issue for insurers and commonplace in clinical trials. Meanwhile, 23andMe and other consumer genetic testing firms are seeing their data sets swell just as their commercial model begins to gel.
- Digital therapeutics prove to be as risky a bet for pharma as drugs – and pharmas clamor to invest and partner. You might think the failure of the most-hyped of Alcon’s partnerships with Alphabet’s Verily, on a blood glucose-reading contact lens, might dampen the fervor for pharma investment in digital or digitally-augmented treatments. But this will probably be the year of the first prescription videogame (Akili’s ADHD treatment is with FDA), and digital treatments for pain are in the works, too (FDA just greenlighted Pear’s app for opioid addiction).
- Biosimilars crash the party, and market themselves much like traditional branded biologics do. Launches of brands looking to play in crowded and lucrative categories like RA and oncology will aim to make a splash, and will air TV ads and field substantial sales forces to generate awareness. But the real competition will be wooing payers, and the makers of incumbent biologics will need to sweeten the pot substantially to preserve their market positions, while trumpeting their trusted-brand status to all stakeholders.
- Political whiplash as Trump actually gets tough with pharma and Brexit causes disruption. It’s one of the biggest wild cards in Washington: Does Trump deal with Congressional Democrats on a plan to Get Pharma? So far, the Trump Administration has talked tough on drug prices but been a pussycat in practice. Democrats will offer Trump an opportunity to play up his Man-of-the-People, anti-establishment cred and join them in soaking Big Bad Pharma. Odds are he’ll take it, particularly as the economic situation and the various investigations darken going into a presidential election cycle, and a Republican Senate may have to play along. Question remains: would bipartisan moves to address pricing tend toward the symbolic (prices in drug ads) or the substantive (say, sanctioning CMS price negotiation with pharmas)? Meanwhile, across the pond, Brexit promises to be highly disruptive to pharmas in 2019, on both sides of the divorce. Hard or soft, “Norway” or No Way, Brexit will cause shortages of therapeutics and force an abrupt realignment of regulatory and administrative structures.
Via Plus91
|
Scooped by
Lionel Reichardt / le Pharmageek
January 2, 2019 3:04 AM
|
À l’occasion des 16es Assises Nationales Hospitalo-Universitaires de Poitiers, l’UNESS présente ce jeudi 13 décembre les résultats de son étude sur la place du numérique dans les formations en Santé portée par toute la communauté universitaire avec le soutien de la Conférence des Doyens de médecine, de pharmacie, d’odontologie, ainsi que de la Conférence des DG de CHU, de l’ISNI et de l’ANEMF.
|
Scooped by
Lionel Reichardt / le Pharmageek
January 2, 2019 3:03 AM
|
PARIS (TICpharma) - La santé connectée fera partie des secteurs phares du millésime 2019 du Consumer Electronic Show (CES), le salon international de la tech, qui se tiendra du 8 au 12 janvier à Las Vegas (Nevada).
A variety of emerging technologies from smart speakers to virtual/augmented reality to wearable devices are expected to change the way healthcare services are delivered. According to Kantar Media’s 2018 Digital Insights Study, 1 out of 4 doctors surveyed indicate they already use one or more of the healthcare technologies measured. 145,000 doctors say they already use smart speakers, virtual/augmented reality, wearable devices, remote monitoring or telemedicine within their practice.
Which specialists are leading the way? Doctors have distinct needs and barriers when it comes to adopting new technologies. New approaches to delivering patient care or training received differing usage scores across physician specialties measured: - Telemedicine – connects patients and doctors remotely allowing for faster delivery/access to healthcare services. Telemedicine is more likely to be practiced by physicians that work in counseling or heavy communication disciplines. For example, 30% of Emergency Medicine specialists and 24% of Psychiatry specialists say they already use telemedicine within their practice.
- Wearable devices for patient self-monitoring – fitness bands, smart watches, glucose meters and other devices can help doctors and patients monitor and manage a condition. 34% of Diabetes/Endocrinology specialists are already using this technology. Additionally, 36% of Cardiology specialists indicate they are very likely to adopt this technology within the next five years (on top of the 16% who already use it). This is good news for patients that notice the value of wearable devices. According to the 2018 MARS Consumer Health study, 29% of adults that feel at risk for Type 2 Diabetes and 27% of adults that feel at risk for Heart Disease say the opportunity to download and share their personal health and fitness data with their doctor or others motivates them.
- Virtual/augmented reality (for training) – is reshaping medical training by allowing doctors to overlay information or images in the world right in front of them. 40% of Pulmonary Disease specialists already use or are very likely to use virtual/augmented reality for training. Additionally, nearly three quarters of Obstetrics/Gynecology specialists indicate they are likely to use it within next five years.
What’s ahead? Overall, doctors expect to see the most growth in telemedicine and wearable device usage in the next five years. Among total doctors surveyed, 62% say their practice is likely to adopt telemedicine; 63% say their practice is likely to adopt wearable devices for patient self-monitoring in the future:
Want to Learn More? Find out how to most effectively engage physicians and allied healthcare professionals with your advertising. Kantar Media’s 2018 Digital Insights Study helps clients navigate the new and changing digital landscape. It includes 20 physician specialties across digital device usage and other topic areas including: - Type and frequency of watching online videos for professional purposes
- Usage of specific social networks within the past 6 months
- General attitudes and opinions about social media
- Usage of specific professional apps within the past 6 months
- Importance and frequency of types of apps used for professional purposes
- Digital advertising attitudes and opinions, including actions taken, ad blocking and tracking, and content targeting
- Use of emerging technologies in practice
Via Plus91
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Doctors Hub
January 2, 2019 2:29 AM
|
Le Top 10 des innovations belges en e-santé les plus lues dans NumeriKare en 2018.
Via Philippe Marchal
The true story behind Twitter’s success belies the conventional wisdom of social networks.
Via Celine Schillinger
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Doctors Hub
January 2, 2019 2:24 AM
|
Doctors have had enough with software that's not useful, so they're inviting entrepreneurs to shadow them.
Via Philippe Marchal
|
Scooped by
Lionel Reichardt / le Pharmageek
December 16, 2018 5:13 AM
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from e-sante
December 15, 2018 10:21 AM
|
|
Scooped by
Lionel Reichardt / le Pharmageek
December 14, 2018 6:55 AM
|
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet
|
Scooped by
Lionel Reichardt / le Pharmageek
December 4, 2018 4:25 PM
|
Healthcare changes dramatically because of technological developments, from anesthetics and antibiotics to magnetic resonance imaging scanners and radiotherapy. Future technological innovation is going to keep transforming healthcare, yet while technologie
|
Scooped by
Lionel Reichardt / le Pharmageek
November 30, 2018 2:01 AM
|
You Won't Find This Information in Publications or Vendor Blogs Just where does one draw the boundaries around "digital health?" This will be a discussion unlike those you see in publications or hear at trade shows. We’ll cut through the noise and conventional thinking to key issues regarding what’s needed and what to avoid, in …
|
|
Scooped by
Lionel Reichardt / le Pharmageek
January 6, 2019 9:43 AM
|
Rock Health has been crunching numbers on the digital health market, and doesn't see a bubble despite the rapid growth.
|
Scooped by
Lionel Reichardt / le Pharmageek
January 3, 2019 3:56 AM
|
eHealthNews.eu proudly presents the top 20 most popular breaking eHealth news from 2018
|
Scooped by
Lionel Reichardt / le Pharmageek
January 2, 2019 3:04 AM
|
L’Autorité de Régulation des Communications Electroniques et des Postes (ACERP) vient de publier son baromètre du numérique 2018. Quels enseignements en
|
Scooped by
Lionel Reichardt / le Pharmageek
January 2, 2019 2:31 AM
|
Des chercheurs néerlandais se sont intéressés à l’efficacité des thérapies sur internet pour les personnes alcooliques. Selon eux, elles peuvent être une première étape utile dans le traitement de la dépendance. .
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Doctors Hub
January 2, 2019 2:29 AM
|
Une étude incluant plus de 1000 généralistes au Royaume-Uni a montré que 72% des généralistes utilisent des outils numériques pour accompagner leurs patients atteints de dépression.
Via Philippe Marchal
De tout temps les hommes ont été malades et de tout temps ils semblent avoir cherché à se soigner.
Via Renaloo
As we learn more about the diseases that affect us, we also get better at controlling them. But will we ever manage to overcome the most inevitable of afflictions – old age?
Via Tonya Scholz
|
Scooped by
Lionel Reichardt / le Pharmageek
December 17, 2018 3:55 PM
|
L’information et la vulgarisation concernant l’évolution de la médecine revu et corrigé par les Nouvelles Techniques de l’Information et de la Communication a été notre credo sur innovationesante.fr, mais l’environnement a beaucoup évolué depuis la création de notre blog il y a maintenant près de trois ans
|
Scooped by
Lionel Reichardt / le Pharmageek
December 15, 2018 10:22 AM
|
Technology is viewed an essential component to substantially improve health care services. It offers great opportunities to address some of the biggest challenges that the mental health sector is currently facing. Despite the many initiatives to improve access to health care, currently only about 40% of people with mental health conditions are receiving proper treatment. According to the Health Foundation and Institute for Fiscal Studies (IFS), financial resources need to more than double to reach 70% of the people who need mental health care. Increasing demands and limited resources necessitate to search for more efficient ways to provide mental health care, i.e. making better use of health technologies. However, despite widespread political agreement about the importance of eHealth, the realization of its benefits has been slow, mostly due to difficulties with adoption and implementation by the sector. In this article we will take a closer look at what we, from both a practical and a scientific point of view, consider one of the most important pitfalls in the adoption of IT by clinical staff.
Technical vs Adaptive change
It was Harvard professor Ronald Heifetz who made clear the distinction between technical versus adaptive change. When dealing with technical change, expertise rules. Problems may be complicated, and require collaboration across disciplines; yet the resolution of the problem is clear and straightforward: follow a series of steps and things go well. For the most part, when we face technical challenges, we focus on improving processes, providing training to improve skills, and doing the right things right. In other words, we know the answer; it is more a matter of careful implementation. Following a recipe is a technical change; so is downloading and then using most apps for your smartphone.
How different things are with adaptive change. Adaptive change requires more than simply sharpening our processes and skills. Instead, adaptive change challenges our beliefs and ways of thinking. It requires that we change our mindset, our mental models of how things should be done. But since our mental models provide internal stability in a world of continuous change, we are often resistant to change. As Heifetz and colleagues stated: Adaptive challenges can only be addressed through changes in people’s priorities, beliefs, habits and loyalties. Making progress requires going beyond any authoritative expertise to mobilize discovery, shedding certain entrenched ways, tolerating losses and generating the new capacity to thrive anew.
|
Scooped by
Lionel Reichardt / le Pharmageek
December 15, 2018 10:12 AM
|
Le directeur des systèmes d'information (DSI) de l'Assistance publique-hôpitaux de Paris (AP-HP), Laurent Treluyer, a indiqué le 3 décembre travailler à la mise en place, au premier semestre 2019, d'un programme de formation continue des professionnels hospitaliers aux outils numériques, et au dossier patient informatisé (DPI) Orbis* en particulier.
|
Scooped by
Lionel Reichardt / le Pharmageek
December 8, 2018 9:56 AM
|
At HIMSS19, ACT | The App Association's Brian Scarpelli will lay out the details of what he calls a "sea change" in CMS' policy toward remote patient monitoring.
|
Scooped by
Lionel Reichardt / le Pharmageek
November 30, 2018 8:09 AM
|
Le 23 novembre, dans le cadre du Festival de la Communication Santé, Techtomed a organisé un atelier sur le thème « Innovation en santé numérique : remettre le patient au centre des préoccupations et de l’innovation. Comment faire de l’offre e-santé une réalité pou
|